Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Reliability of Amniocentesis
4.2.2 Growing Median Age of First-Time Motherhood
4.2.3 Increasing Burden of Congenital Disorders
4.3 Market Restraints
4.3.1 Availability of Alternate Methods
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 100 to 150 mm Needles
5.1.2 Larger Than 150 mm Needles
5.1.3 Smaller Than 100 mm Needles
5.2 By Procedure
5.2.1 Amniocentesis Procedures
5.2.2 Amnioreduction Procedures
5.2.3 Fetal Blood Transfusion Procedures
5.2.4 Amnioinfusion Procedures
5.2.5 Cordocentesis Procedures
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 The Ccoper Companis Inc.
6.1.2 Becton, Dickinson and Company
6.1.3 Cook Medical Incorporated
6.1.4 RI.MOS. Srl
6.1.5 Tsunami Medical
6.1.6 Smiths Medical
6.1.7 Laboratoire Ccd
6.1.8 Integra Lifesciences
6.1.9 Medtronic Plc
6.1.10 Medline Industries Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS